Results 201 to 210 of about 8,328 (212)

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane   +43 more
wiley   +1 more source

Reperfusion‐Dependent Outcomes After Endovascular Thrombectomy Stratified by NIHSS‐ASPECTS Clinical‐Core Mismatch

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This analysis evaluates the effect of successful reperfusion on functional outcomes after MT, stratified by admission National Institutes of Health Stroke Scale (NIHSS) and Alberta Stroke Program Early CT Score (ASPECTS) as surrogates for clinical‐core mismatch, using multicenter registry data.
Felix Schlicht   +53 more
wiley   +1 more source

Function and evolution of the plant MADS-box gene family

Nature Reviews Genetics, 2001
Martin F Yanofsky, Yanofsky Martin F
exaly  

Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement

American Journal of Respiratory and Critical Care Medicine, 2017
Bruce H Culver   +2 more
exaly  

A multiple lyapunov function approach to stabilization of fuzzy control systems

IEEE Transactions on Fuzzy Systems, 2003
Hua O Wang
exaly  

Thymic function and leukemia

Ca-A Cancer Journal for Clinicians, 1990
exaly  

High-Throughput Characterization of Plant Gene Functions by Using Gain-of-Function Technology

Annual Review of Plant Biology, 2010
Youichi Kondou   +2 more
exaly  

Broad Work‐Function Tunability of p‐Type Conjugated Polyelectrolytes for Efficient Organic Solar Cells

Advanced Energy Materials, 2015
Byoung Hoon Lee   +2 more
exaly  

Home - About - Disclaimer - Privacy